Company
Every investor coverage indicates participated in a round PainChek raised.
Companies PainChek acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Philip Daffas | CEO | Dealroom |
Stories naming PainChek. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
ASX-listed digital health firm PainChek has agreed to raise 5.5 million dollars via convertible notes from prior shareholders, funding working capital and a North American sales push after signing a US aged-care deal.
Techboard's monthly roundup logs June 2022 Australian funding events, including GO1's Series E, Edrolo's Series B, two acquisitions, several new funds reaching closes, and accelerator intake announcements.
Also Techboard
Western Australia's government is distributing $8 million through its new Innovation Seed Fund to 17 health research projects, including $500,000 for medtech VeinTech, and has opened the Major Research Application Support program.